Literature DB >> 23689576

Short-term complications of membranous nephropathy.

Sean Barbour1, Heather Reich, Daniel Cattran.   

Abstract

Short-term complications of membranous nephropathy (MN) are important components of the process and their proper management can significantly alter the outcomes of patients with this disease. These complications vary from the non-specific ones associated with many types of chronic kidney disease such as hypertension, proteinuria and the symptoms associated with the nephrotic syndrome including edema and dyslipidemia. These are briefly discussed in the chapter. In addition, there are some specific issues more commonly associated with MN than other types of glomerulonephritis. This includes a hypercoagulable state and the associated thromboembolism. There is more recent information in this domain and this is included in the chapter. The associated increased risk of infection in MN patients is the final chapter component. This section is included to remind us not only of the direct impact of that disease process on reducing resistance to infection, but also to indicate the need to consider prophylactic antibiotics when the addition of potent immunosuppressive drug treatment is required for these patients.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689576     DOI: 10.1159/000349976

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  11 in total

Review 1.  Primary Membranous Nephropathy.

Authors:  William G Couser
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-26       Impact factor: 8.237

2.  Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy.

Authors:  Tian-tian Li; Xiao-hui Zhang; Jing-feng Jing; Xin Li; Xiao-qian Yang; Feng-hua Zhu; Wei Tang; Jian-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2015-01-26       Impact factor: 6.150

3.  Clinical and pathologic features of primary membranous nephropathy in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group.

Authors:  Abdulmecit Yildiz; Sena Ulu; Aysegul Oruc; Ali Riza Ucar; Savas Ozturk; Selma Alagoz; Necmi Eren; Ismail Kocyigit; Simal Koksal Cevher; Ali Burak Haras; Abdullah Sumnu; Turgay Arinsoy; Garip Sahin; Gultekin Suleymanlar; Caner Cavdar; Gizem Kumru Sahin; Ilhan Kurultak; Abdulkadir Unsal; Gulizar Sahin; Sinan Kazan; Erhan Tatar; Mehmet Dıkec; Belda Dursun; Hayriye Sayarlioglu; Kultigin Turkmen; Ayse Serra Artan; Nimet Aktas; Zulfikar Yilmaz; Ahmet Behlul; Hamad Dheir; Sim Kutlay; Nurhan Seyahi
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

4.  Management of Patients With Glomerulonephritis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team.

Authors:  Sarah M Moran; Sean Barbour; Christine Dipchand; Jocelyn S Garland; Michelle Hladunewich; Arenn Jauhal; Joanne E Kappel; Adeera Levin; Sanjay Pandeya; Heather N Reich; Susan Thanabalasingam; Dorothy Thomas; Jeffrey C Ma; Christine White
Journal:  Can J Kidney Health Dis       Date:  2020-11-26

5.  Toxic Nephropathy Secondary to Chronic Mercury Poisoning: Clinical Characteristics and Outcomes.

Authors:  Zhenzhen Gao; Na Wu; Xuqin Du; Huiling Li; Xue Mei; Yuguo Song
Journal:  Kidney Int Rep       Date:  2022-03-18

Review 6.  Primary Membranous Glomerulonephritis: The Role of Serum and Urine Biomarkers in Patient Management.

Authors:  Sadiq Mu'azu Maifata; Rafidah Hod; Fadhlina Zakaria; Fauzah Abd Ghani
Journal:  Biomedicines       Date:  2019-11-01

7.  Statins can benefit patients with primary membranous nephropathy on venous thromboembolism.

Authors:  Peimei Zou; Hang Li; Jianfang Cai; Zhenjie Chen; Chao Li; Xuewang Li
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

8.  The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis.

Authors:  Balazs Odler; Martin Windpessl; Marcell Krall; Maria Steiner; Regina Riedl; Carina Hebesberger; Martin Ursli; Emanuel Zitt; Karl Lhotta; Marlies Antlanger; Daniel Cejka; Philipp Gauckler; Martin Wiesholzer; Marcus Saemann; Alexander R Rosenkranz; Kathrin Eller; Andreas Kronbichler
Journal:  Front Immunol       Date:  2021-10-29       Impact factor: 7.561

9.  Microhematuria Enhances the Risks of Relapse and Renal Progression in Primary Membranous Nephropathy.

Authors:  Peng He; Xiaoyong Yu; Yang Zha; Jing Liu; Hanmin Wang; Chen Huang; Shiren Sun; Lijie He
Journal:  Front Med (Lausanne)       Date:  2021-12-09

10.  Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome.

Authors:  Tianxin Chen; Ying Zhou; Xinxin Chen; Bo Chen; Jingye Pan
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.